NCT00003606View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

October 1, 1999

Study Completion Date

June 30, 2001

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

epirubicin hydrochloride

DRUG

etoposide

RADIATION

radiation therapy

Trial Locations (1)

34295

Hopital Arnaud de Villeneuve, Montpellier

All Listed Sponsors
lead

UNICANCER

OTHER

NCT00003606 - Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter